Gemelli Biotech Revenue and Competitors
Estimated Revenue & Valuation
- Gemelli Biotech's estimated annual revenue is currently $4.5M per year.
- Gemelli Biotech's estimated revenue per employee is $155,000
Employee Data
- Gemelli Biotech has 29 Employees.
- Gemelli Biotech grew their employee count by -15% last year.
Gemelli Biotech's People
Name | Title | Email/Phone |
---|---|---|
1 | Founder & CEO | Reveal Email/Phone |
2 | VP Finance and Analytics | Reveal Email/Phone |
3 | VP Sales and Market Access | Reveal Email/Phone |
4 | Director Business Development | Reveal Email/Phone |
5 | Director Business Development | Reveal Email/Phone |
6 | Director Business Development | Reveal Email/Phone |
7 | Senior Director Marketing Operations | Reveal Email/Phone |
8 | Director Business Development | Reveal Email/Phone |
9 | Director Business Development | Reveal Email/Phone |
10 | Associate Marketing Director | Reveal Email/Phone |
Gemelli Biotech Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $4.4M | 57 | -8% | $53M | N/A |
#2 | $21.2M | 137 | -26% | $110M | N/A |
#3 | $0.9M | 6 | 0% | N/A | N/A |
#4 | $2.3M | 15 | 15% | N/A | N/A |
#5 | $1.6M | 10 | -17% | N/A | N/A |
#6 | $0.7M | 9 | 50% | N/A | N/A |
#7 | $11.5M | 74 | -12% | N/A | N/A |
#8 | $0.4M | 275 | 10% | $236.7M | N/A |
#9 | $4M | 51 | -74% | $160M | N/A |
#10 | $2.3M | 15 | 15% | N/A | N/A |
What Is Gemelli Biotech?
Gemelli Biotech is a specialty biotechnology company that strives to achieve a thriving global family of healthy individuals by unlocking the potential of the microbiome. Gemelli's mission is to support the discovery of novel diagnostics and therapeutics for the human microbiome by bringing biotechnology innovations to market in a fiscally responsible and socially conscious way. Gemelli Biotech is proud to partner closely with Cedars-Sinai Medical Center in Los Angeles, ranked by US News and World Report as one of the top 10 hospitals in the nation. The Medically Associated Science and Technology (MAST) program at Cedars-Sinai is dedicated to the development of lab tests, drugs and devices to diagnose and treat patients and works closely with Gemelli. Alignment with MAST allows Gemelli to operate on the cutting edge, with an early look at the newest scientific discoveries related to the microbiome. In the fall of 2018, Gemelli launched ibs-smart, the groundbreaking blood test for Mixed-Type and Diarrhea Predominant Irritable Bowel Syndrome. An exciting pipeline of innovation is set to follow in 2019.
keywords:N/AN/A
Total Funding
29
Number of Employees
$4.5M
Revenue (est)
-15%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Gemelli Biotech News
Gemelli Biotech: Gemelli is a biotechnology firm that specializes in the microbiome and IBS diagnostics. MemberHub: MemberHub offers online...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $2M | 29 | -9% | N/A |
#2 | N/A | 29 | 4% | N/A |
#3 | $4.6M | 29 | N/A | N/A |
#4 | $2.9M | 29 | N/A | N/A |
#5 | $3.3M | 29 | -15% | N/A |